0001014108-23-000032.txt : 20230213 0001014108-23-000032.hdr.sgml : 20230213 20230213122152 ACCESSION NUMBER: 0001014108-23-000032 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ugwumba Chidozie CENTRAL INDEX KEY: 0001835544 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39834 FILM NUMBER: 23616110 MAIL ADDRESS: STREET 1: 158 FILMORE STREET CITY: DENVER STATE: CO ZIP: 80206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clene Inc. CENTRAL INDEX KEY: 0001822791 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 852828339 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-676-9695 MAIL ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: Chelsea Worldwide Inc. DATE OF NAME CHANGE: 20200827 5 1 primary_doc.xml PRIMARY DOCUMENT X0306 5 2022-12-31 0 0 1 0001822791 Clene Inc. CLNN 0001835544 Ugwumba Chidozie 609 SW 8TH STREET, SUITE 365 BENTONVILLE AR 72712 1 0 0 0 Common Stock 2022-12-31 4 J 0 L 1019210 0 A 5548019 I By SymBiosis II, LLC The shares are directly held by SymBiosis II, LLC. Amount reflects an additional 1,019,210 shares located in a separate brokerage account during the issuer's fiscal year. /s/Chidozie Ugwumba 2023-02-10